narvo vexar
- Merck’s (MRK) veterinary division, Merck Animal Health, on Thursday announced an agreement to acquire TARGAN, a biodevice solutions developer targeting the poultry industry, for an undisclosed sum.
- The transaction expected to close in Q3 2026 will add TARGAN’s automated gender
